Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Ortokirurgi Aalborg ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.7% 0.7%   Bankruptcy risk   2.4% 1.2% 1.3% 0.9% 0.8% 0.9% 5.8% 5.8%   Credit score (0-100)   65 83 80 87 92 88 40 40   Credit rating   BBB A A A AA A BBB BBB   Credit limit (kDKK)   0.0 85.6 55.9 371.3 560.7 550.6 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   714 4,145 4,611 5,565 5,279 5,942 0.0 0.0   EBITDA   378 2,669 2,425 2,829 2,503 2,257 0.0 0.0   EBIT   190 2,244 2,019 2,187 1,803 1,549 0.0 0.0   Pre-tax profit (PTP)   120.0 2,126.7 1,910.0 2,213.1 1,788.5 1,349.1 0.0 0.0   Net earnings   87.5 1,657.0 1,480.8 1,719.2 1,394.0 1,049.6 0.0 0.0   Pre-tax profit without non-rec. items   120 2,127 1,910 2,213 1,788 1,349 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   654 1,240 1,084 1,960 3,268 1,774 0.0 0.0   Shareholders equity total   138 1,795 2,275 2,995 4,389 5,438 5,388 5,388   Interest-bearing liabilities   5,046 3,659 5,082 5,359 1,453 3,251 0.0 0.0   Balance sheet total (assets)   5,347 6,624 8,788 9,322 6,789 10,033 5,388 5,388   Net Debt   5,046 2,798 4,969 4,070 977 3,251 -3,574 -3,574     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   714 4,145 4,611 5,565 5,279 5,942 0.0 0.0   Gross profit growth   0.0% 480.8% 11.2% 20.7% -5.1% 12.6% -100.0% 0.0%   Employees   1 4 4 5 5 6 0 0   Employee growth %   0.0% 300.0% 0.0% 25.0% 0.0% 20.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   5,347 6,624 8,788 9,322 6,789 10,033 5,388 5,388   Balance sheet change%   0.0% 23.9% 32.7% 6.1% -27.2% 47.8% -46.3% 0.0%   Added value   378.5 2,668.8 2,425.3 2,829.0 2,444.8 2,256.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   4,941 -69 -2,590 100 473 -2,336 -1,774 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   26.6% 54.1% 43.8% 39.3% 34.2% 26.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   3.6% 37.5% 26.5% 25.5% 22.7% 19.6% 0.0% 0.0%   ROI %   3.6% 40.8% 30.5% 28.2% 24.4% 21.3% 0.0% 0.0%   ROE %   63.6% 171.5% 72.8% 65.2% 37.8% 21.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   2.6% 27.1% 25.9% 32.1% 64.6% 54.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   1,333.3% 104.8% 204.9% 143.9% 39.0% 144.1% 0.0% 0.0%   Gearing %   3,668.8% 203.9% 223.3% 178.9% 33.1% 59.8% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.8% 2.7% 3.1% 1.8% 1.3% 12.6% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.1 0.4 1.3 1.2 1.7 1.8 0.0 0.0   Current Ratio   0.1 0.4 1.3 1.2 1.7 1.8 0.0 0.0   Cash and cash equivalent   0.0 861.1 113.1 1,288.4 475.5 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,308.2 -1,692.2 1,295.2 690.8 625.7 2,915.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   378 667 606 566 489 376 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   378 667 606 566 501 376 0 0   EBIT / employee   190 561 505 437 361 258 0 0   Net earnings / employee   88 414 370 344 279 175 0 0